The chemotherapeutic effects of H+/K+ inhibitors on Helicobacter pylori infection

Pharmacology and Therapeutics

Volumn 69, Issue 1, 1996, Pages 79-83

  Logan, Robert P H ^a,b  

^a Parkside Helicobacter Study Group   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

acid; Helicobacter; proton pump inhibitors

Indexed keywords

AG 1812; AG 2000; AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; UNCLASSIFIED DRUG; UREASE;

ENZYME ACTIVITY; GASTRITIS; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; PEPTIC ULCER; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0030049829     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(95)02032-2     Document Type: Review

References (50)

1. Arachimandritis, C., Tjivras, M., Davaris, P. and Fertakis, A. (1991) Effect of omeprazole on H. pylori after 2 weeks of treatment. Ital. J. Gastroenterol. 23: 357-358.
2. Axon, A. R. (1991) Duodenal ulcer: the villain unmasked? Br. Med. J. 302: 919-921.
3. Batten, J., Logan, R. P. H., Gummett, P. A., Walker, M. M., Baron, J. H. and Misiewicz, J. J. (1991) Does the specific urease activity of Helicobacter pylori determine the distribution and extent of infection. Ital. J. Gastroenterol. 23 (Suppl. 2): 54.
4. Bazzoli, F., Zagari, R. M., Fossi, S., Pozzato, P., Alampi, G., Simoni, P., Sottili, S., Roda, A. and Roda, E. (1994) Short term, low dose triple therapy for eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 6: 773-777.
5. Bell, D. G., Powell, K., Weil, J., Burridge, S. M., Morden, A., Harrison, G., Gant, P. W., Jones, P. H. and Trowell, J. E. (1991) Experience with omeprazole in combination with either amoxycillin or colloidal bismuth subcitrate in patients with metronidazole-resistant Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 3: 923-926.
6. Biasco, G., Miglioli, M., Barbara, L., Corinaldesi, R. and Di Febo, G. (1989) Omeprazole, Helicobacter pylori, gastritis an duodenal ulcer. Lancet ii: 1403.
7. Bugnoli, M., Bayeli, P. F., Rappuoli, R., Pennatini, C., Figura, N. and Crabtree, J. E. (1993) Inhibition of Helicobacter pylori urease by omeprazole. Eur. J. Gastroenterol. Hepatol. 5: 683-686.
8. Danon, S. J., O'Rourke, J. L., Moss, N. D. and Lee, A. (1995) The importance of local acid production in the distribution of Helicobacter felis in the moust stomach. Gastroenterology 108: 1386-1395.
9. Daw, M. A., Deegan, P. and O'Morain, C. (1991) The effect of omeprazole on Helicobaaer pylori and associated gastritis. Aliment. Pharmacol. Ther. 5: 435-439.
10. De Koster, E., Nyst, J. F., Deprez, C., Glupczynski, J. C., Denis, P., Van Geel, J., Buset, M., De Reuck, M. and Deltenre, M. (1991) Hp treatment: disappointing results with amoxicillin plus omeprazole. Ital. J. Gastroenterol. 23 (Suppl. 2): 105.
11. Eaton, K. A., Brooks, C. L., Morgan, D. R. and Krakowka, S. (1991) Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnobiotic piglets. Infect. Immun. 59: 2470-2475.
12. Falkinham, J. O. and Hoffman, P. S. (1984) Unique development of the swarm and short cells of Proteus vulgaris and Proteus mirabilis. J. Bacteriol. 158: 1037-1040.
13. Ferrero, R. L., Hazell, S. L. and Lee, A. (1988) The urease enzymes of Campylobacter pylori and a related bacterium. J. Med. Microbiol. 27: 34-40.
14. Figura, N., Armellini, D., Bugnoli, M., Bayeli, P. F., Gennari, C. and Crabtree, J. E. (1994) Activity of omeprazole on H. pylori and relation to toxicity of strains. J. Clin. Pathol. 47: 440-442.
15. Ghelani, A. M., Hale, S., Coleman, H., Radziwonik, H., Robertson, C. and Atkinson, M. (1990) Lack of in vitro activity of omeprazole against Campylobacter pylori. J. Clin. Pathol. 43: 171-172.
16. Graham, D. Y. (1989) Campylobacter pylori and peptic ulcer disease. Gastroenterology 96: 615-625.
17. Graham, D. Y., Lew, G. M., Evans, D. G., Evand, D. J. and Klein, P. D. (1991) Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann. Intern. Med. 115: 266-269.
18. Hellander, H. (1988) Physiology and pharmacology of the parietal cell. Baillieres Clin. Gastroenterol. 2: 539-554.
19. Hui, W. M., Lam, S. K., Ho, J., Lai, C. L., Lok, A. S. F. and Ng, M. M. T. (1991) Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig. Dis. Sci. 36: 577-582.
20. Iwahi, T., Satoh, H., Masafumi, N., Iwaski, T., Yamazaki, T. and Kubo, K. (1991) Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob. Agents Chemother. 35: 490-496.
21. Jhala, N. C., McFarland, M., Brightman, S., Morale, B., Jennings, D., Greski-Rose, P., Rubin, W. and Atkinson, B. F. (1992) Effect of short term treatment with lansoprazole on H. pylori and antral gastritis in patients with duodenal ulcer. Gastroenterology 102: A91.
22. Labenz, J., Gyenes, E., Rhul, G. H. and Borsch, G. (1991) Amoxycillin-omeprazole treatment for eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 3 (Suppl. 1): S10.
23. Lage, A. P. and Glupczynski, Y. (1994) Omeprazole exerts the same inhibitory effect on the growth of cytotoxic-positive and cytotoxic-negative H. pylori strains and does not inhibit vacuolating toxin production. Eur. J. Gastroenterol. Hepatol. 6: 299-301.
24. Lamouliatte, H., Bernard, P. H., Cayla, R., Vialette, G., Quinton, A., Megraud, F. and Lemaire, M. (1992) Effect of lansoprazole against Helicobacter pylori in vivo. Gastroenterology 102: A106.
25. Logan, R. P. H., Gummett, P. A., Misiewicz, J. J., Karim, Q. N., Walker, M. M. and Baron, J. H. (1991) A one week eradication regime for Helicobacter pylori. Lancet 338: 1249-1252.
26. Logan, R. P. H., Rubio, M. A., Gummett, P. A., Hegarty, B., Walker, M. M., Baron, J. H. and Misiewicz, J. J. (1992) Omeprazole and amoxycillin suspension for Helicobacter pylori. Ital. J. Med. Sci. 161 (Suppl. 10): 16.
27. Logan, R. P. H., Gummett, P. A., Schaufelberger, H. D. S., Greaves, R. R. F. H., Mendelson, G. M., Walker, M. M., Karim, Q. N. Baron, J. H. and Misiewicz, J. J. (1994) Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 35: 232-236.
28. Logan, R. P. H., Bardhan, K. D., Celestin, L. R., Theodossi, A., Palmer, K. R., Reed, P. I., Baron, J. H. and Misiewicz, J. J. (1995a) Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomised, double blind, multicentre trial or omprazole with or without clarithromycin. Aliment. Pharmacol. Ther. 9: 417-423.
29. Logan, R. P. H., Walker, M. M., Misiewicz, J. J., Gummett, P. A. and Baron, J. H. (1995b) Changes in the intragastric distribution of H. pylori during treatment with omeprazole. Gut 36: 12-16.
30. Mainguet, P., Delmee, M. and Debongnie, J.-C. (1989) Omeprazole, Campylobacter pylori and duodenal ulcer. Lancet ii: 389-390.
31. Maton, P. N. (1991) Omeprazole. N. Engl. J. Med. 324: 965-975.
32. Mauch, F., Bode, G. and Malfertheiner, P. (1993) Identification and characterisation of an ATPase system of H. pylori and the effect of proton pump inhibitors. Am. J. Gastroenterol. 88: 1801-1802.
33. McGowan, C. C., Cover, T. L. and Blaser, M. J. (1994) The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 107: 738-743.
34. McTavish, D., Buckley, M. M.-T. and Heel, R. C. (1991) Omeprazole. An updated review of its pharmacology and therapeutic use in acid related disorders. Drugs 42: 138-170.
35. Megraud, F., Boyanova, L. and Lamouliatte, H. (1991) Activity of lansoprazole against Helicobacter pylori. Lancet 337: 1486.
36. Mobley, H. L. T. and Hausinger, R. P. (1989) Microbial ureases: significance, regulation and molecular characterisation. Microbiol. Rev. 53: 85-108.
37. Nagata, K., Satoh, H., Iwahi, T., Shimoyama, T. and Tamura, T. (1993) Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob. Agents Chemother. 37: 769-774.
38. Neri, M., Susi, D., Bovani, I., Pindo, R. and Cuccurullo, F. (1992) Omeprazole, bismuth and clarithromycin: a new strategy for the treatment of Helicobacter pylori (HP) related gastritis. Ital. J. Med. Sci. 161 (Suppl. 10): 3.
39. Rauws, E. A. J. and Tytgat, G. N. J. (1990) Cure of duodenal ulcer with eradication of Helicobacter pylori. Lancet 335: 1233-1235.
40. Rauws, E. A., Langenberg, W., Houthoff, H. J., Zanen, H. C. and Tytgat, G. N. J. (1988) Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94: 33-40.
41. Sharp, J., Logan, R. P. H., Walker, M. M., Gummett, P. A., Misiewicz, J. J. and Baron, J. H. (1991) Effect of omeprazole on Helicobacter pylori. Gut 32: A565.
42. Siurala, M., Sipponen, P. and Kekki, M. (1988) Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut 29: 909-915.
43. Sjostrom, J. W., Berglund, M. L., Fryklund, J., Kuhler, T. and Larson, H. (1993) Factors affecting the antibacterial activity of omeprazole and structural analogues in vitro. Acta Gastroenterol. Belg. 56 (Suppl.): 144.
44. Stoke, M. and Bethke, B. (1990) Elimination of Helicobacter pylori under treatment with omeprazole. Z. Gastroenterol. 28: 271-274.
45. Suerbaum, S., Leying, H., Klemm, K. and Opferkuch, W. (1991) Anti-bacterial activity of pantropazole and omeprazole against H. pylori. Eur. J. Clin. Microbiol. Infect. Dis. 10: 92-93.
46. Tessaro, P., Di Mario, F., Rugge, M., Batta, R., Pasqualetti, P. and Vio, A. (1990) Efficacy of omeprazole in eradicating Helicobacter pylori from the gastric mucosa. Eur. J. Gastroenterol. Hepatol. 2: S117-S118.
47. Unge, P., Gad, A., Eriksson, K., Bergman, B., Carling, L., Ekstrom, P., Glise, H., Gnarpe, H., Junghard, O., Lindholmer, C., Dandzen, B., Strandberg, L., Stubberod, A. and Weywadt, L. (1993) Amoxycillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur. J. Gastroenterol. Hepatol. 5: 325-331.
48. Verdu, E., Viani, F., Armstrong, D., Fraser, R., Siegrist, H. H., Pignatelli, B., Idstrom, J. P., Cederberg, C., Blum, A. L. and Fried, M. (1994) Effect of omeprazole on the intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut 35: 455-460.
49. Vigneri, S., Termini, R., Scialabba, A., Pisciotta, G. and Di Mario, F. (1991) Omeprazole therapy modifies the gastric localisation of Helicobacter pylori. Am. J. Gastroenterol. 86: 1276.
50. Weil, J., Bell, D. G., Powell, K., Morden, A., Harrison, G., Gant, P. W., Jones, P. H. and Trowell, J. E. (1991) Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment. Pharmacol. Ther. 5:309-313.